News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
751,037 Results
Type
Article (45267)
Company Profile (336)
Press Release (705422)
Multimedia
Podcasts (113)
Webinars (19)
Section
Business (212394)
Career Advice (2113)
Deals (36523)
Drug Delivery (118)
Drug Development (82646)
Employer Resources (177)
FDA (16972)
Job Trends (15410)
News (357405)
Policy (33611)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2721)
Accelerated approval (32)
Adcomms (24)
Allergies (146)
Alliances (52619)
ALS (172)
Alzheimer's disease (1694)
Antibody-drug conjugate (ADC) (324)
Approvals (17235)
Artificial intelligence (563)
Autoimmune disease (156)
Automation (40)
Bankruptcy (366)
Best Places to Work (11930)
BIOSECURE Act (20)
Biosimilars (191)
Biotechnology (222)
Bladder cancer (159)
Brain cancer (57)
Breast cancer (646)
Cancer (4880)
Cardiovascular disease (404)
Career advice (1789)
Career pathing (37)
CAR-T (295)
CDC (45)
Celiac Disease (2)
Cell therapy (776)
Cervical cancer (36)
Clinical research (70402)
Collaboration (1785)
Company closure (4)
Compensation (1171)
Complete response letters (55)
COVID-19 (2797)
CRISPR (97)
C-suite (876)
Cystic fibrosis (149)
Data (6285)
Decentralized trials (2)
Denatured (43)
Depression (134)
Diabetes (505)
Diagnostics (6967)
Digital health (51)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (269)
Drug pricing (187)
Drug shortages (30)
Duchenne muscular dystrophy (236)
Earnings (91876)
Editorial (58)
Employer branding (22)
Employer resources (157)
Events (122170)
Executive appointments (1009)
FDA (20148)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1526)
Gene editing (210)
Generative AI (50)
Gene therapy (627)
GLP-1 (987)
Government (4767)
Grass and pollen (7)
Guidances (385)
Healthcare (19597)
HIV (62)
Huntington's disease (44)
IgA nephropathy (83)
Immunology and inflammation (253)
Immuno-oncology (58)
Indications (111)
Infectious disease (3073)
Inflammatory bowel disease (193)
Inflation Reduction Act (14)
Influenza (120)
Intellectual property (256)
Interviews (327)
IPO (16989)
IRA (51)
Job creations (3831)
Job search strategy (1500)
JPM (61)
Kidney cancer (16)
Labor market (86)
Layoffs (562)
Leadership (33)
Legal (8171)
Liver cancer (93)
Longevity (14)
Lung cancer (651)
Lymphoma (379)
Machine learning (44)
Management (63)
Manufacturing (817)
MASH (164)
Medical device (14519)
Medtech (14574)
Mergers & acquisitions (20618)
Metabolic disorders (1282)
Multiple sclerosis (160)
NASH (16)
Neurodegenerative disease (320)
Neuropsychiatric disorders (88)
Neuroscience (2940)
Neurotech (1)
NextGen: Class of 2026 (6852)
Non-profit (4652)
Now hiring (67)
Obesity (600)
Opinion (272)
Ovarian cancer (167)
Pain (200)
Pancreatic cancer (231)
Parkinson's disease (283)
Partnered (34)
Patents (509)
Patient recruitment (500)
Peanut (59)
People (61162)
Pharmaceutical (70)
Pharmacy benefit managers (29)
Phase 1 (22107)
Phase 2 (30955)
Phase 3 (22973)
Pipeline (5332)
Policy (290)
Postmarket research (2583)
Preclinical (9460)
Press Release (71)
Prostate cancer (241)
Psychedelics (48)
Radiopharmaceuticals (298)
Rare diseases (847)
Real estate (6284)
Recruiting (70)
Regulatory (25122)
Reports (52)
Research institute (2528)
Resumes & cover letters (364)
Rett syndrome (27)
RNA editing (19)
RSV (78)
Schizophrenia (151)
Series A (252)
Series B (194)
Service/supplier (14)
Sickle cell disease (98)
Special edition (21)
Spinal muscular atrophy (158)
Sponsored (42)
Startups (3880)
State (2)
Stomach cancer (17)
Supply chain (105)
Tariffs (84)
The Weekly (68)
Vaccines (1046)
Venture capital (93)
Weight loss (386)
Women's health (92)
Worklife (18)
Date
Last 7 days (626)
Last 30 days (2059)
Last 365 days (30526)
2026 (3512)
2025 (30958)
2024 (36216)
2023 (41135)
2022 (52398)
2021 (56994)
2020 (55612)
2019 (48407)
2018 (36441)
2017 (33540)
2016 (33139)
2015 (39360)
2014 (32941)
2013 (27985)
2012 (30242)
2011 (30847)
2010 (28809)
Location
Africa (777)
Alabama (86)
Alaska (7)
Arizona (319)
Arkansas (14)
Asia (41950)
Australia (6969)
California (11502)
Canada (3311)
China (1130)
Colorado (488)
Connecticut (490)
Delaware (348)
Europe (92073)
Florida (1701)
Georgia (368)
Hawaii (3)
Idaho (64)
Illinois (889)
India (66)
Indiana (530)
Iowa (23)
Japan (440)
Kansas (130)
Kentucky (40)
Louisiana (27)
Maine (72)
Maryland (1401)
Massachusetts (8327)
Michigan (350)
Minnesota (647)
Mississippi (6)
Missouri (139)
Montana (35)
Nebraska (28)
Nevada (125)
New Hampshire (85)
New Jersey (3052)
New Mexico (30)
New York (3020)
North Carolina (1501)
North Dakota (10)
Northern California (5591)
Ohio (343)
Oklahoma (22)
Oregon (44)
Pennsylvania (2305)
Puerto Rico (25)
Rhode Island (49)
South America (1166)
South Carolina (67)
South Dakota (1)
Southern California (4480)
Tennessee (178)
Texas (1785)
United States (40930)
Utah (343)
Vermont (1)
Virginia (267)
Washington D.C. (82)
Washington State (943)
West Virginia (4)
Wisconsin (119)
Wyoming (2)
751,037 Results for "nanostring technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
NanoString Technologies to Be Acquired by Bruker Corporation
NanoString Technologies, Inc. (“NanoString” or “the Company”) today announced that substantially all of its assets will be acquired by Bruker Corporation (“Bruker”), a global life science analytical instrument company, for approximately $392.6 million in cash consideration, plus the assumption of certain liabilities.
April 17, 2024
·
6 min read
Press Releases
DW Healthcare Partners Announces Sale of LKC Technologies to AMETEK, Inc.
February 3, 2026
·
2 min read
Press Releases
Scryb Inc. Provides Early Warning Update on Holdings in Cybeats Technologies Corp.
January 15, 2026
·
5 min read
Deals
Bruker to Acquire the NanoString Business in an Asset Deal
Bruker Corporation announced that it has entered into a definitive acquisition agreement with NanoString Technologies, Inc., headquartered in Seattle, Washington, a leading provider of solutions for spatial transcriptomics and gene expression analysis.
April 22, 2024
·
7 min read
Deals
Bruker Completes Asset Acquisition of NanoString Business
Bruker Corporation announced that it has closed its asset acquisition of the business of NanoString Technologies, Inc., headquartered in Seattle, Washington, a leading provider of life-science research solutions for spatial transcriptomics and gene expression analysis.
May 6, 2024
·
7 min read
BioForest
NanoString’s CosMx SMI Achieves Whole Transcriptome Imaging at Single-Cell Resolution
NanoString Technologies, Inc. announced the release of the first public dataset of the whole transcriptome obtained at true single-cell resolution on the CosMx™ Spatial Molecular Imager.
January 7, 2024
·
6 min read
Deals
Patient Square Capital, a Leading Health Care-Focused Investment Firm, Agrees to Acquire NanoString Technologies
NanoString Technologies, Inc. announced that it has reached an agreement with Patient Square Capital, a prominent health care investment firm, pursuant to which Patient Square will serve as the “stalking horse” bidder in conjunction with a court-supervised sales process.
March 10, 2024
·
7 min read
Business
NanoString Technologies Releases Operating Results for Third Quarter of 2023
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the third quarter ended September 30, 2023.
November 6, 2023
·
17 min read
Press Releases
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN
January 16, 2026
·
3 min read
Press Releases
Medical Care Technologies Inc. (OTC Pink:MDCE) Announces Attendance at CES 2026 in Las Vegas
January 7, 2026
·
2 min read
1 of 75,104
Next
